Abstract P6-13-05: Association between the UGT2B17 gene deletion, exemestane metabolites and vasomotor QOL in women participating on the MAP3 prevention trial Article

Richardson, H, Knight, B, Chen, G et al. (2019). Abstract P6-13-05: Association between the UGT2B17 gene deletion, exemestane metabolites and vasomotor QOL in women participating on the MAP3 prevention trial . CANCER RESEARCH, 79(4_Supplement), p6-13-05-p6-13-05. 10.1158/1538-7445.sabcs18-p6-13-05

cited authors

  • Richardson, H; Knight, B; Chen, G; Luo, S; Massey, T; Goss, PE; Lazarus, P

authors

publication date

  • February 15, 2019

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3205 Medical Biochemistry and Metabolomics
  • 6.1 Pharmaceuticals
  • Aging
  • Breast Cancer
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Estrogen
  • Genetics
  • Prevention
  • Women's Health

Digital Object Identifier (DOI)

publisher

  • American Association for Cancer Research (AACR)

start page

  • p6-13-05-p6-13-05

volume

  • 79

issue

  • 4_Supplement